Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 3/20 | 0.45 |
| ▸ | HCRTR2 | O43614 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | DHODH | Q02127 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL873577 | 0.93 | LMNA (0.47) | HCRTR1HCRTR2MAPK1TSHRROCK2 | |
| SCHEMBL845290 | 0.91 | HCRTR1 (0.52) | HCRTR1HCRTR2MEN1KMT2AMAPK1 | |
| SCHEMBL874313 | 0.91 | MAPK1 (0.50) | MEN1KMT2AMAPK1TSHRROCK2 | |
| SCHEMBL845539 | 0.87 | HCRTR1 (0.54) | HCRTR1HCRTR2MEN1KMT2AMAPK1 | |
| SCHEMBL10119619 | 0.87 | MAPK1 (0.46) | MEN1KMT2AMAPK1ROCK2ALDH1A1 | |
| SCHEMBL845629 | 0.86 | TSHR (0.50) | HCRTR1HCRTR2MEN1KMT2AMAPK1 | |
| SCHEMBL845002 | 0.84 | CYP2C9 (0.55) | HCRTR1HCRTR2MAPK1TSHRALDH1A1 | |
| SCHEMBL845000 | 0.83 | RHOC (0.51) | MAPK1TSHRROCK2ALDH1A1MAPT | |
| SCHEMBL872930 | 0.82 | GAA (0.52) | HCRTR1HCRTR2MEN1KMT2AMAPK1 | |
| SCHEMBL10119551 | 0.81 | DHODH (0.40) | ROCK2ALDH1A1MAPTCYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143288-B2 | Inhibitors of HCV replication | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-27 | — | — | US | disclosed |